Results from the ongoing AReSVi-006 phase III trial show vaccine … D ‘Risk factors” in the company’s Annual Report on Form 20-F for 2022, …
A Site About 3D Stuff
GSK shares positive data for Arexvy, its respiratory syncytial virus (RSV) older adult vaccine …
Back To Top